CompletedPhase 3

Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)

United States600 participantsStarted 2003-12

Plain-language summary

The purpose of this study is to investigate the safety and effectiveness of ciclesonide nasal spray as compared with placebo (inactive substance) nasal spray in relieving symptoms of perennial allergic rhinitis.

Who can participate

Age range12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Main Inclusion Criteria: * General good health, other than perennial allergic rhinitis * History and diagnosis of perennial allergic rhinitis by skin prick test Main Exclusion Criteria: * Participation in any investigational drug trial within the 30 days preceding the Screening Visit * A known hypersensitivity to any corticosteroid or any of the excipients in the formulation * Use of any prohibited concomitant medications as defined by the study protocol

What they're measuring

change in Total Nasal Symptom Scores.

Trial details

NCT IDNCT00163501

SponsorAstraZeneca

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2005-04

View on ClinicalTrials.gov More Perennial Allergic Rhinitis trials